Cystatin C-derived estimated glomerular filtration rate in children with sickle cell anaemia.
Children
Cystatin C
Decreased GFR
Glomerular filtration rate (GFR)
Hyperfiltration
Sickle cell anaemia
Journal
BMC nephrology
ISSN: 1471-2369
Titre abrégé: BMC Nephrol
Pays: England
ID NLM: 100967793
Informations de publication
Date de publication:
29 Nov 2023
29 Nov 2023
Historique:
received:
04
06
2023
accepted:
08
11
2023
medline:
1
12
2023
pubmed:
30
11
2023
entrez:
29
11
2023
Statut:
epublish
Résumé
Sickle cell disease is the most common inherited blood disorder in humans and constitutes a major public health burden. It is a multisystemic condition with long-term renal complications. Early detection of sickle cell nephropathy and initiation of appropriate interventions are associated with improved survival and quality of life. This study aimed to compare the cystatin C-derived estimated glomerular filtration rate (GFR) of the study groups and also, to correlate the clinical features of chronic kidney disease (CKD) with decreased GFR in children with sickle cell anaemia (SCA). This hospital-based cross-sectional analytic study recruited 86 SCA subjects in steady-state and 86 age and sex-matched healthy HbAA controls aged 1-14 years who attended the Paediatric Haematology and Outpatient clinics of Federal Medical Centre Bida over six months. Data were collected using a semi-structured questionnaire, and participants' length/height, weight, and blood pressure were measured using standard procedures. Blood samples were drawn for serum cystatin C assay via the sandwich enzyme-linked immunosorbent assay (ELISA) technique. Filler's equation was used to calculate the glomerular filtration rate. There was a significant difference in the mean cystatin C-derived GFR between the two groups, i.e. 116 ± 30mL/min/1.73m Supernormal GFR is common in children with SCA and there is no significant association between clinical features of CKD with decreased GFR. Regular evaluation of renal function is, however, recommended in children with SCA for early detection and treatment of renal complications in order to halt the progression to end-stage kidney disease (ESKD).
Sections du résumé
BACKGROUND
BACKGROUND
Sickle cell disease is the most common inherited blood disorder in humans and constitutes a major public health burden. It is a multisystemic condition with long-term renal complications. Early detection of sickle cell nephropathy and initiation of appropriate interventions are associated with improved survival and quality of life. This study aimed to compare the cystatin C-derived estimated glomerular filtration rate (GFR) of the study groups and also, to correlate the clinical features of chronic kidney disease (CKD) with decreased GFR in children with sickle cell anaemia (SCA).
METHODS
METHODS
This hospital-based cross-sectional analytic study recruited 86 SCA subjects in steady-state and 86 age and sex-matched healthy HbAA controls aged 1-14 years who attended the Paediatric Haematology and Outpatient clinics of Federal Medical Centre Bida over six months. Data were collected using a semi-structured questionnaire, and participants' length/height, weight, and blood pressure were measured using standard procedures. Blood samples were drawn for serum cystatin C assay via the sandwich enzyme-linked immunosorbent assay (ELISA) technique. Filler's equation was used to calculate the glomerular filtration rate.
RESULTS
RESULTS
There was a significant difference in the mean cystatin C-derived GFR between the two groups, i.e. 116 ± 30mL/min/1.73m
CONCLUSIONS
CONCLUSIONS
Supernormal GFR is common in children with SCA and there is no significant association between clinical features of CKD with decreased GFR. Regular evaluation of renal function is, however, recommended in children with SCA for early detection and treatment of renal complications in order to halt the progression to end-stage kidney disease (ESKD).
Identifiants
pubmed: 38031035
doi: 10.1186/s12882-023-03393-x
pii: 10.1186/s12882-023-03393-x
pmc: PMC10688062
doi:
Substances chimiques
Cystatin C
0
Creatinine
AYI8EX34EU
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
349Informations de copyright
© 2023. The Author(s).
Références
Am J Hypertens. 1989 Jan;2(1):2-8
pubmed: 2643968
BMC Nephrol. 2013 Oct 30;14:237
pubmed: 24168027
Arch Dis Child. 2015 Jan;100(1):48-53
pubmed: 25239949
Clin J Am Soc Nephrol. 2011 Nov;6(11):2628-33
pubmed: 21940843
Hypertension. 2017 Oct;70(4):683-686
pubmed: 28827475
Pediatr Hematol Oncol. 2015 May;32(4):250-7
pubmed: 23987825
Am J Hematol. 2019 Apr;94(4):417-423
pubmed: 30592084
PLoS Med. 2013;10(7):e1001484
pubmed: 23874164
J Pediatr. 2010 Jan;156(1):66-70.e1
pubmed: 19880138
Arch Intern Med. 1981 Jun;141(7):891-3
pubmed: 7235808
Front Med (Lausanne). 2022 Oct 21;9:1029224
pubmed: 36341242
Nat Rev Dis Primers. 2018 Mar 15;4:18010
pubmed: 29542687
Am J Hematol. 2011 Jul;86(7):559-66
pubmed: 21630304
Kidney Int. 2004 Apr;65(4):1416-21
pubmed: 15086483
Ann Hematol. 2011 Dec;90(12):1371-9
pubmed: 21901339
Kidney Int. 2006 Jun;69(11):2070-7
pubmed: 16612328
Niger J Med. 2002 Jan-Mar;11(1):23-5
pubmed: 12073296
Clin Hemorheol Microcirc. 2018;68(2-3):205-221
pubmed: 29614633
Pediatr Nephrol. 2003 Oct;18(10):981-5
pubmed: 12920638
Pediatr Nephrol. 2011 Aug;26(8):1285-90
pubmed: 21559933
Pediatr Nephrol. 2006 Apr;21(4):533-7
pubmed: 16491413
Blood. 2010 Jun 3;115(22):4331-6
pubmed: 20233970
BMC Nephrol. 2015 May 29;16:75
pubmed: 26021375
Nat Rev Nephrol. 2015 Mar;11(3):161-71
pubmed: 25668001
Am J Kidney Dis. 1998 Aug;32(2):208-14
pubmed: 9708603
Nat Commun. 2010 Nov 02;1:104
pubmed: 21045822